Virginia A. Schad, PharmD, RPh

Does use of CPAP or high-flow nasal oxygen by inpatients with COVID-19 expose nearby healthcare workers to a greater risk of viral contamination?

Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.

Children with congenital heart disease and comorbid obstructive sleep apnea are at increased risk for impaired neurocognition compared with children with congenital heart disease who do not have comorbid OSA.

Physiologic traits that cause obstructive sleep apnea are also associated with adherence to continuous positive airway pressure in patients with stroke.

Patients with obstructive sleep apnea and daytime sleepiness still receive a substantial benefit from suboptimal continuous positive airway pressure adherence.

Loop gain measured noninvasively from polysomnography can be influenced by respiratory event scoring in obstructive sleep apnea.

A remote electrical neuromodulation (REN) device may offer a safe and effective non-pharmacologic alternative for acute migraine treatment.

Neurocardiac injury detected by strain imaging appears to be a marker for the extent of neurological insult, and is a new prognostic marker in patients with SAH.

Several reports describe a possible association between restless legs syndrome and Parkinson disease, as well as Tourette syndrome and restless legs syndrome.

Total tau and phosphorylated tau follow a different pattern of change in Alzheimer disease.

An acute diffusion-weighted imaging lesion may predict an increased long-term risk for recurrent ischemic stroke after transient ischemic attack or minor stroke.

Cyclic vomiting syndrome (CVS) and benign paroxysmal torticollis (BPT) during infancy are associated with a high risk for developing headache later in life.

In patients with chronic migraine (CM) and medication overuse, erenumab reduces migraine frequency.

Careful multidisciplinary team discussion may avoid unnecessary intervention in patients with carotid stenosis presenting with stroke or transient ischemic attack.

Rivaroxaban was associated with a reduced recurrent stroke risk in patients with embolic stroke of undetermined source.

A single dose of nilotinib reduces inflammation and alpha-synuclein in patients with Parkinson’s disease.

The Liverpool Adverse Events Profile questionnaire may be a useful tool for identifying people with epilepsy who may be at higher risk for suicidality.

Motor complications are associated with suicidal ideation in Parkinson disease.

AQB-565 may represent a novel treatment for infantile spasms with potentially limited adverse events.

Investigators conducted a prespecified analyses to evaluate the extent to which icosapent ethyl decreases total ischemic events.

Researchers analyzed the causal relevance of lifelong differences in low-density lipoprotein cholesterol for ischemic stroke relative to that for coronary heart disease.